[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4398 followers
Created: 2025-07-17 11:30:06 UTC

$ALDX New Product Launches:

On July 17, 2025, Aldeyra Therapeutics announced that the FDA accepted its New Drug Application for reproxalap, aimed at treating dry eye disease, with a decision expected by December 16, 2025.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945808223610486960/c:line.svg)

**Related Topics**
[$aldx](/topic/$aldx)
[sec](/topic/sec)

[Post Link](https://x.com/USCorpFilings/status/1945808223610486960)